Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Safety of short-term valacyclovir as an anti-sickling agent in sickle-cell anemia.

Ender KL, DeBellis RH, Erlanger BF, Billote GB, Brittenham GM.

Pediatr Blood Cancer. 2011 May;56(5):843-5. doi: 10.1002/pbc.22809. Epub 2011 Jan 13.

2.

Immunochemical recognition of A2E, a pigment in the lipofuscin of retinal pigment epithelial cells.

Abeywickrama C, Matsuda H, Jockusch S, Zhou J, Jang YP, Chen BX, Itagaki Y, Erlanger BF, Nakanishi K, Turro NJ, Sparrow JR.

Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14610-5. Epub 2007 Sep 5.

3.

Cell cycle inhibition by an anti-cyclin D1 antibodychemically modified for intracellular delivery.

Chen BX, Erlanger BF.

Cancer Lett. 2006 Nov 28;244(1):71-5. Epub 2006 Jan 27.

PMID:
16442707
4.

A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties.

Ali SS, Hardt JI, Quick KL, Kim-Han JS, Erlanger BF, Huang TT, Epstein CJ, Dugan LL.

Free Radic Biol Med. 2004 Oct 15;37(8):1191-202.

PMID:
15451059
5.

Inhibition of sickling in vitro by three purine-based antiviral agents: an approach to the treatment of sickle cell disease.

DeBellis RH, Chen BX, Erlanger BF.

Blood Cells Mol Dis. 2003 Sep-Oct;31(2):286-90.

PMID:
12972037
6.

Intracellular delivery of monoclonal antibodies.

Chen BX, Erlanger BF.

Immunol Lett. 2003 Aug 5;88(2):87. No abstract available.

PMID:
12924401
7.

Intracellular delivery of monoclonal antibodies.

Chen BX, Erlanger BF.

Immunol Lett. 2002 Oct 21;84(1):63-7.

PMID:
12161285
8.

Cellular localisation of a water-soluble fullerene derivative.

Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, Larroque C.

Biochem Biophys Res Commun. 2002 May 31;294(1):116-9.

PMID:
12054749
9.

Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance.

Dong Q, Ginsberg HN, Erlanger BF.

Diabetes Obes Metab. 2001 Oct;3(5):360-6.

PMID:
11703426
10.

X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60).

Braden BC, Goldbaum FA, Chen BX, Kirschner AN, Wilson SR, Erlanger BF.

Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12193-7.

11.

A1 adenosine receptor of human and mouse adipose tissues: cloning, expression, and characterization.

Tatsis-Kotsidis I, Erlanger BF.

Biochem Pharmacol. 1999 Oct 15;58(8):1269-77.

PMID:
10487528
12.
13.

Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.

Chen BX, Wilson SR, Das M, Coughlin DJ, Erlanger BF.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10809-13.

14.

Antibodies to oxidative DNA damage: characterization of antibodies to 8-oxopurines.

Ide H, Kow YW, Chen BX, Erlanger BF, Wallace SS.

Cell Biol Toxicol. 1997 Oct;13(6):405-17.

PMID:
9352119
15.

A strategy for immunohistochemical signal enhancement by end-product amplification.

Chen BX, Szabolcs MJ, Matsushima AY, Erlanger BF.

J Histochem Cytochem. 1996 Aug;44(8):819-24.

PMID:
8756754
16.

Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody.

Franke EK, Chen BX, Tatsis I, Diamanduros A, Erlanger BF, Luban J.

J Virol. 1995 Sep;69(9):5821-3.

17.

Idiotypic mimicry and the assembly of a supramolecular structure: an anti-idiotypic antibody that mimics taxol in its tubulin-microtubule interactions.

Leu JG, Chen BX, Diamanduros AW, Erlanger BF.

Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10690-4. Erratum in: Proc Natl Acad Sci U S A 1995 Jan 17;92(2):646.

18.

Human mononuclear phagocytes express adenosine A1 receptors. A novel mechanism for differential regulation of Fc gamma receptor function.

Salmon JE, Brogle N, Brownlie C, Edberg JC, Kimberly RP, Chen BX, Erlanger BF.

J Immunol. 1993 Sep 1;151(5):2775-85.

PMID:
8360491
19.

Why cyclosporin is an effective drug.

Erlanger BF.

Immunol Today. 1993 Jul;14(7):369. No abstract available.

PMID:
8363728
20.

Characterization of polyclonal and monoclonal anti-taxol antibodies and measurement of taxol in serum.

Leu JG, Chen BX, Schiff PB, Erlanger BF.

Cancer Res. 1993 Mar 15;53(6):1388-91.

21.

Mimicking ligands.

Erlanger BF.

Nature. 1993 Jan 21;361(6409):211-2. No abstract available.

PMID:
8423848
22.

Immunoassay of taxol and taxol-like compounds in plant extracts.

Leu JG, Jech KS, Wheeler NC, Chen BX, ERlanger BF.

Life Sci. 1993;53(12):PL183-7.

PMID:
8103185
23.

Do we know the site of action of cyclosporin?

Erlanger BF.

Immunol Today. 1992 Dec;13(12):487-90. Review.

PMID:
1334415
25.

Evidence for a functional receptor for cyclosporin A on the surface of lymphocytes.

Cacalano NA, Chen BX, Cleveland WL, Erlanger BF.

Proc Natl Acad Sci U S A. 1992 May 15;89(10):4353-7.

26.

Properties of a monoclonal antibody for the detection of abasic sites, a common DNA lesion.

Chen BX, Kubo K, Ide H, Erlanger BF, Wallace SS, Kow YW.

Mutat Res. 1992 May;273(3):253-61.

PMID:
1374846
28.

Novel monoclonal antibodies to cyclosporine A: characterization and epitope mapping with cyclosporine analogs and cyclophilin.

Cacalano NA, Aggarwal R, Quesniaux VF, Cleveland WL, Erlanger BF.

Mol Immunol. 1992 Jan;29(1):107-18.

PMID:
1370570
29.

Characterization of a monoclonal anti-idiotypic antibody that mimics cyclosporine A in a single binding system.

Cacalano NA, Cleveland WL, Erlanger BF.

J Immunol. 1991 Nov 1;147(9):3012-7.

PMID:
1717584
30.

Antibodies to receptors by an auto-anti-idiotypic strategy.

Erlanger BF.

Biochem Soc Trans. 1991 Feb;19(1):138-43. Review. No abstract available.

PMID:
1828047
31.

Characterization of a monoclonal antibody to thymidine glycol monophosphate.

Chen BX, Hubbard K, Ide H, Wallace SS, Erlanger BF.

Radiat Res. 1990 Nov;124(2):131-6.

PMID:
2247592
32.

Immunohistochemical localization of renal mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal image of aldosterone.

Lomb├Ęs M, Farman N, Oblin ME, Baulieu EE, Bonvalet JP, Erlanger BF, Gasc JM.

Proc Natl Acad Sci U S A. 1990 Feb;87(3):1086-8.

33.

A syngeneic monoclonal anti-idiotypic antibody with internal image properties restricted to a single aldosterone-binding system.

Lombes M, Desfosses B, Cittanova N, Erlanger BF.

J Immunol. 1989 Dec 15;143(12):4078-83.

PMID:
2531777
34.

Characterization of antibodies to dihydrothymine, a radiolysis product of DNA.

Hubbard K, Ide H, Erlanger BF, Wallace SS.

Biochemistry. 1989 May 16;28(10):4382-7.

PMID:
2669952
35.

Some thoughts on the structural basis of internal imagery.

Erlanger BF.

Immunol Today. 1989 May;10(5):151-2.

PMID:
2742741
36.

Immunochemical quantitation of thymine glycol in oxidized and X-irradiated DNA.

Hubbard K, Huang H, Laspia MF, Ide H, Erlanger BF, Wallace SS.

Radiat Res. 1989 May;118(2):257-68.

PMID:
2524860
37.

Identification of an epitope shared by the DNA-binding domain of glucocorticoid receptor and the B chain of insulin.

Cayanis E, Sarangarajan R, Lombes M, Nahon E, Edelman IS, Erlanger BF.

Proc Natl Acad Sci U S A. 1989 Apr;86(7):2138-42.

38.

Antibodies to cyclosporine A (CsA) by a novel route and their use to monitor cyclosporine levels by radioimmunoassay (RIA).

Cacalano NA, Cleveland WL, Erlanger BF.

J Immunol Methods. 1989 Mar 31;118(2):257-63.

PMID:
2647858
39.
40.
41.

Probing the surface of Z-DNA with anti-nucleoside antibodies.

Nahon E, Grunberger D, Erlanger BF.

Biochemistry. 1988 Jul 12;27(14):5193-8.

PMID:
2844253
42.

Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.

Hill BL, Erlanger BF.

Endocrinology. 1988 Jun;122(6):2840-50. Erratum in: Endocrinology 1988 Oct;123(4):2123. Endocrinology 1988 Sep;123(3):1525.

PMID:
2453350
43.

Z DNA and loop structures by immunoelectronmicroscopy of supercoiled pRW751, a plasmid containing left-handed helices.

Castleman H, Hanau LH, Zacharias W, Erlanger BF.

Nucleic Acids Res. 1988 May 11;16(9):3977-96.

44.

Immunocytochemical evidence for methylation of the inactive X chromosome in human fetal oogonia.

Jagiello GM, Tantravahi U, Ducayen MB, Erlanger BF.

Proc Soc Exp Biol Med. 1987 Nov;186(2):223-8.

PMID:
3671360
45.

Monoclonal antibodies to adenosine receptor by an auto-anti-idiotypic approach.

Ku HH, Cleveland WL, Erlanger BF.

J Immunol. 1987 Oct 1;139(7):2376-84.

PMID:
3655366
46.

Characterization of a bioeffective monoclonal antibody against thyrotropin beta-subunit.

Hill BL, Lustbader JW, Erlanger BF.

Endocrinology. 1987 Feb;120(2):574-81.

PMID:
2433128
47.

Autoantibodies to receptors by an autoantiidiotypic route.

Erlanger BF, Cleveland WL, Wassermann NH, Ku HH, Hill BL, Sarangarajan R, Penn AS.

Ann N Y Acad Sci. 1987;505:416-22. No abstract available.

PMID:
3500668
48.

Auto-anti-idiotype: a basis for autoimmunity and a strategy for anti-receptor antibodies.

Erlanger BF, Cleveland WL, Wassermann NH, Ku HH, Hill BL, Sarangarajan R, Rajagopalan R, Cayanis E, Edelman IS, Penn AS.

Immunol Rev. 1986 Dec;94:23-37. No abstract available.

PMID:
3492425
49.

Generation of an auto-anti-idiotypic antibody that binds to glucocorticoid receptor.

Cayanis E, Rajagopalan R, Cleveland WL, Edelman IS, Erlanger BF.

J Biol Chem. 1986 Apr 15;261(11):5094-103.

50.

New amiloride analogue as hapten to raise anti-amiloride antibodies.

Kleyman TR, Rajagopalan R, Cragoe EJ Jr, Erlanger BF, Al-Awqati Q.

Am J Physiol. 1986 Jan;250(1 Pt 1):C165-70.

PMID:
3079960

Supplemental Content

Loading ...
Support Center